The Asia Pacific Newborn Screening Market Is Growing with Increasing Incidence of Neonatal Diseases
Every newborn is tested for a group of health disorders that are not otherwise found at birth. Infants are most vulnerable to diseases such as COPD, asthma, encephaliphitis, epilepsy, polio, and other respiratory disease, anemia, leukemia, diarrhea, and other rare diseases that results in substantial economic burden. Newborn screening describes various tests that are performed during first few hours or days of a newborn’s life. With a simple blood test, doctors can check for hormone-related, genetic, rare, and metabolic conditions that can cause serious health problems. Newborn screening helps prevent severe health problems and death.
Rising cases of congenital diseases in newborns, growing neonatal population base, favorable government programs and legislations, and technological advancements are some of the major factors driving the Asia Pacific newborn screening market growth. According to World Health Organization (WHO) and the Ministry of Defence (India) report, birth defects account for 7% of all neonatal mortality and 3.3 million under five deaths. The prevalence of birth defects in India is 6-7% which translates to around 1.7 million birth defects annually. Moreover, WHO recommended a newborn screening program to safeguard the health of children worldwide.
Furthermore, WHO is allocating necessary resources as an additional investment of US$ 0.20 cents per person, which can save 2 of every 3 newborns in low and middle income countries by 2030. Thus, the demand for newborn screening is increasing to tackle infectious diseases, such as streptococcal pharyngitis, malaria, chickenpox, whooping cough, influenza, rubella, tuberculosis, polio, mumps, and measles. For instance, Ministry of Health and Family Welfare, the Government of India, provides several vaccines to infants, children, and pregnant women through the Universal Immunization Programme. According to the WHO, worldwide, around 86% of infants are vaccinated against 26 diseases in 2018.
The Asia Pacific newborn screening market is rapidly gaining traction in the Asia Pacific, due to the increasing birth rate and the increasing incidence of neonatal diseases in this region. According to UNICEF India, with the birth of 25 million children each year India accounts for nearly one fifth of the world’s annual child births. Around 46% of all maternal deaths and 40% of neonatal deaths happen during labour or the first 24 hours after birth. Pre-maturity (35 %), neonatal infections (33%), birth asphyxia (20%) and congenital malformations (9%) are among the major causes of new-born deaths. Therefore, there is an increasing demand for newborn screening in this region, driving the Asia Pacific newborn screening market growth.
Comments
Post a Comment